Home › Calculator › NNVC Dividend Calculator 2026
NNVC Dividend DRIP Calculator 2026
146.52% YieldHealthcareNanoViricides, Inc. · AMEX
Price: $1.37 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NNVC pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NNVC snowball 📈
$10,000 in NNVC → $82.89M in 10 years · $4,105,706.05/month
About NanoViricides, Inc. (NNVC) — Dividend Analysis 2026
NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses. For herpes-related conditions, it offers HerpeCide in multiple forms: dermal topical and eye drops to treat ailments such as shingles, postherpetic neuralgia (PHN), chickenpox, recurrent herpes labialis, genital herpes, and ocular herpes keratitis. An intraocular injectable version of HerpeCide is also under development for viral acute retinal necrosis. Another significant therapeutic candidate is FluCide, a broad-spectrum anti-influenza nanoviricide, designed for both hospitalized patients via injection and outpatients through an oral formulation. NanoViricides also develops specialized nanoviricide eye drops for viral diseases affecting the external eye, DengueCide for various strains of Dengue viruses, and HIVCide, an anti-HIV nanoviricide specifically engineered to resist viral escape. Furthermore, the company is actively advancing additional nanoviricide drug projects targeting a diverse range of viruses and indications, alongside expanding its HerpeCide program to encompass a broader spectrum of herpes viruses and associated conditions. NanoViricides, Inc. was established in 2005 and maintains its corporate headquarters in Shelton, Connecticut.
Compare NNVC with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NNVC DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NNVC position with:
🌍 NNVC Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NNVC.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 146.52% | 143.72% | $14,652 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 124.54% | 121.74% | $12,454 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 117.22% | 114.42% | $11,722 / yr |
| 🇬🇧 UK ISA | 0% | 146.52% | 143.72% | $14,652 / yr |
| 🇬🇧 UK Taxable | 8.75% | 133.70% | 130.90% | $13,370 / yr |
| 🇨🇦 TFSA | 0% | 146.52% | 143.72% | $14,652 / yr |
| 🇨🇦 CA Taxable | 25% | 109.89% | 107.09% | $10,989 / yr |
| 🇦🇺 Super (pension) | 15% | 124.54% | 121.74% | $12,454 / yr |
| 🇦🇺 AU Taxable | 30% | 102.56% | 99.76% | $10,256 / yr |
| 🇩🇪 DE Taxable | 26.375% | 107.88% | 105.08% | $10,788 / yr |
| 🇫🇷 FR Taxable | 30% | 102.56% | 99.76% | $10,256 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NNVC Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NNVC Dividend Payment Schedule
NNVC pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NNVC vs Healthcare Benchmarks
How NNVC compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NNVC sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NNVC Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| G-Gift | 2022-08-08 | 94,471 | — | — | ||
| M-Exempt | 2018-05-21 | 5,500,000 | $1.00 | $5.50M | ||
| M-Exempt | 2017-02-21 | 1,746,288 | $1.15 | $2.01M | ||
| A-Award | 2017-07-11 | 120,744 | $1.38 | $166.6K | ||
| A-Award | 2017-05-04 | 149,478 | $1.11 | $165.9K | ||
| A-Award | 2017-02-21 | 153,611 | $1.08 | $165.9K | ||
| A-Award | 2018-05-21 | 150,000 | — | — | ||
| J-Other | 2017-02-01 | 1 | $3.50 | $4.00 |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NNVC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
NanoViricides, Inc. (NNVC) is currently trading at $1.37, 73% below its 52-week high. The current dividend yield is 146.52% based on an annual payout of $2.00 per share.
NNVC (NanoViricides, Inc.) — 146.52% Dividend Yield Analysis
NanoViricides, Inc. (NNVC) is a healthcare stock currently trading at $1.36 with a dividend yield of 146.52%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (146.52%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest NNVC News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.